BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31764269)

  • 1. Integrating Economic Evaluation and Implementation Science to Advance the Global HIV Response.
    Salomon JA
    J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3():S314-S321. PubMed ID: 31764269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of health economic evaluation in the implementation and improvement science fields-a systematic literature review.
    Roberts SLE; Healey A; Sevdalis N
    Implement Sci; 2019 Jul; 14(1):72. PubMed ID: 31307489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed-method approaches to strengthen economic evaluations in implementation research.
    Dopp AR; Mundey P; Beasley LO; Silovsky JF; Eisenberg D
    Implement Sci; 2019 Jan; 14(1):2. PubMed ID: 30635001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
    Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S
    Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review.
    Malhotra A; Thompson RR; Kagoya F; Masiye F; Mbewe P; Mosepele M; Phiri J; Sambo J; Barker A; Cameron DB; Davila-Roman VG; Effah W; Hutchinson B; Laxy M; Newsome B; Watkins D; Sohn H; Dowdy DW
    Implement Sci; 2022 Nov; 17(1):76. PubMed ID: 36384807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis in Implementation Science: a Research Agenda and Call for Wider Application.
    Krebs E; Nosyk B
    Curr HIV/AIDS Rep; 2021 Jun; 18(3):176-185. PubMed ID: 33743138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation in implementation science: Making the business case for implementation strategies.
    Eisman AB; Kilbourne AM; Dopp AR; Saldana L; Eisenberg D
    Psychiatry Res; 2020 Jan; 283():112433. PubMed ID: 31202612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Differentiated Service Delivery for HIV Treatment: Effectiveness, Mechanisms, Targeting, and Scale.
    Roy M; Bolton Moore C; Sikazwe I; Holmes CB
    Curr HIV/AIDS Rep; 2019 Aug; 16(4):324-334. PubMed ID: 31230342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond cost-effectiveness, morbidity and mortality: a comprehensive evaluation of priority setting for HIV programming in Uganda.
    Kapiriri L; Lee NM; Wallace LJ; Kwesiga B
    BMC Public Health; 2019 Apr; 19(1):359. PubMed ID: 30935380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs.
    Lambdin BH; Cheng B; Peter T; Mbwambo J; Apollo T; Dunbar M; Udoh IC; Cattamanchi A; Geng EH; Volberding P
    Curr HIV Res; 2015; 13(3):244-9. PubMed ID: 25986374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation science issues in understanding, collecting, and using cost estimates: a multi-stakeholder perspective.
    Eisman AB; Quanbeck A; Bounthavong M; Panattoni L; Glasgow RE
    Implement Sci; 2021 Aug; 16(1):75. PubMed ID: 34344411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repositioning Implementation Science in the HIV Response: Looking Ahead From AIDS 2018.
    Hargreaves J; Dalal S; Rice B; Anderegg N; Bhattacharjee P; Gafos M; Hensen B; Mangenah C; Quaife M; Padian N
    J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3():S299-S304. PubMed ID: 31764267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending analytic methods for economic evaluation in implementation science.
    O'Leary MC; Hassmiller Lich K; Frerichs L; Leeman J; Reuland DS; Wheeler SB
    Implement Sci; 2022 Apr; 17(1):27. PubMed ID: 35428260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation science perspectives and opportunities for HIV/AIDS research: integrating science, practice, and policy.
    Glasgow RE; Eckstein ET; Elzarrad MK
    J Acquir Immune Defic Syndr; 2013 Jun; 63 Suppl 1():S26-31. PubMed ID: 23673882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of pharmacogenomics: a value-based approach to pragmatic decision making in the face of complexity.
    Snyder SR; Mitropoulou C; Patrinos GP; Williams MS
    Public Health Genomics; 2014; 17(5-6):256-64. PubMed ID: 25278172
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.